Your browser doesn't support javascript.
loading
Patient, Parent, and Oncologist Perspectives and Recommendations on the Right Way to Talk About Prognosis in Advanced Childhood Cancer.
Kaye, Erica C; Farner, Harmony; Mehler, Shoshana; Bien, Kelly; Mali, Nidhi; Brinkman, Tara M; Baker, Justin N; Hinds, Pamela; Mack, Jennifer W.
Afiliação
  • Kaye EC; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
  • Farner H; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
  • Mehler S; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
  • Bien K; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
  • Mali N; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.
  • Brinkman TM; Department of Psychology and Biobehavioral Sciences, St Jude Children's Research Hospital, Memphis, TN.
  • Baker JN; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Hinds P; Department of Pediatrics, Stanford University, Palo Alto, CA.
  • Mack JW; Department of Nursing Science, Professional Practice & Quality, Children's National Hospital, Washington, DC.
JCO Oncol Pract ; : OP2400249, 2024 Sep 06.
Article em En | MEDLINE | ID: mdl-39241207
ABSTRACT

PURPOSE:

Clear prognostic communication is associated with improvements in quality of life and suffering for children with advanced illness. Yet recent evidence demonstrates that pediatric oncologists often avoid, defer, or soften prognostic disclosure. We aimed to describe pediatric cancer shareholder perspectives on quality prognostic communication to inform design of an intervention to improve prognostic disclosure in advanced childhood cancer.

METHODS:

Semi-structured interviews were conducted with a purposeful sample of pediatric patients with cancer (n = 20), parents (n = 20), and oncologists (n = 20) representing six institutions across five states. Rapid analysis was performed using the National Cancer Institute core communication functions to organize domains of inquiry.

RESULTS:

Three main themes were endorsed by participants regarding the ideal timing of prognostic disclosure early, ongoing, individualized. Although each group emphasized the need for an individualized approach, oncologists rarely elicited patient/parent preferences for prognostic communication and more commonly inferred what a patient/family wanted to hear. Participants described five key pillars for how to facilitate quality prognostic disclosure conversation leadership, overall attendance, patient inclusion, location, and atmosphere. They also identified four themes around ideal prognostic content range of information, use of numbers, population-level versus patient-specific information, and tone/delivery. Discordant recommendations between patients/parents and oncologists emerged for how much and what information to share.

CONCLUSION:

Pediatric cancer shareholders advocated for diverse, and sometimes conflicting, approaches for prognostic disclosure. Although nearly all participants endorsed the importance of individualized prognostic disclosure, specific strategies to encourage or facilitate person-centered prognostic conversation are lacking. Future research will focus on collaboration with pediatric patients, parents, and oncologists to codesign a clinical intervention to improve prognostic communication for children with advanced cancer and their families.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Oncol Pract / JCO oncology practice (Online) Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JCO Oncol Pract / JCO oncology practice (Online) Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos